Exogenous surfactant supplementation in infants with respiratory syncytial virus bronchiolitis

American Journal of Respiratory and Critical Care Medicine

Volumn 162, Issue 4 I, 2000, Pages 1251-1256

  Tibby, S M ^a   Hatherill, M ^a   Wright, S M ^a   Wilson, P ^a   Postle, A D ^a   Murdoch, I A ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIPALMITOYLPHOSPHATIDYLCHOLINE; LUNG SURFACTANT; LUNG SURFACTANT EXTRACT; PLACEBO;

ARTICLE; BRONCHIOLITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GAS EXCHANGE; HUMAN; INFANT; LUNG COMPLIANCE; LUNG LAVAGE; LUNG MECHANICS; MALE; OXYGENATION; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS;

EID: 0033778256     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.162.4.9909004     Document Type: Article

References (33)

1. Intensive care course and outcome of patients infected with respiratory syncytial virus
2. Acute respiratory distress syndrome caused by respiratory syncytial virus
3. Ribavirin for respiratory syncytial virus lower respiratory tract infection
4. Corticosteroids do not affect the clinical or physiological status of infants with bronchiolitis
5. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children
6. Compliance of the respiratory system in newborn infants pre- and postsurfactant replacement therapy
7. Surfactant content in children with inflammatory lung disease
8. Surfactant abnormalities in infants with severe viral bronchiolitis
9. Abnormal surfactant composition and activity in severe bronchiolitis
10. Surfactant dysfunction develops in BALB/c mice infected with respiratory syncytial virus
11. Surfactant effects on fluid-elastic instabilities of liquid-lined flexible tubes: A model of airway closure
12. Pulmonary surfactant maintains patency of conducting airways in the rat
13. Management of acute bronchiolitis
14. Phosphatidylcholine composition of endotracheal tube aspirates of neonates and subsequent respiratory disease
15. Passive respiratory mechanics in newborns and children
16. Phosphorous assay in column chromatography
17. A rapid method of total lipid extraction and purification
18. Deficient hydrophilic lung surfactant proteins A and D with normal surfactant phospholipid molecular species in cystic fibrosis
19. Albuterol responsiveness in infants with respiratory failure caused by respiratory syncytial virus infection
20. Treatment of respiratory failure due to respiratory syncytial virus pneumonia with natural surfactant
21. Porcine-derived surfactant treatment of severe bronchiolitis
22. Developmental variation in whole human lung phosphatidylcholine molecular species: A comparison with guinea pig and rat
23. A comparison of the specificity of phosphatidylcholine synthesis by human fetal lung maintained in either organ or organotypic culture
24. Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection
25. Turnover of exogenous artificial surfactant
26. Surfactant phosphatidylcholine source, fluxes and turnover times in 3-day-old, 10-day-old and adult rabbits
27. Synthesis of phosphatidylcholine in fetal guinea-pig lung involves acyl remodeling and differential turnover of individual molecular species
28. Endogenous surfactant turnover in preterm infants measured with stable isotopes
29. Endogenous surfactant metabolism in critically ill infants measured with stable isotope labeled fatty acids
30. Disruption of pulmonary surfactant's ability to maintain openness of a narrow tube
31. Mucus rheology and transport in neonatal respiratory distress syndrome and the effect of surfactant therapy
32. Leakage of protein in the immature rabbit lung; effect of surfactant replacement
33. A biophysical mechanism by which plasma proteins inhibit lung surfactant activity